IBECTA

Welcome to the Brand page for “IBECTA”, which is offered here for Anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; pharmaceutical preparations for the treatment and prevention of diseases and disorders of the autoimmune system, the metabolic system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the treatment of eye diseases and conditions; pharmaceutical preparations for the treatment of heart rhythm disorders; pharmaceutical preparations for the treatment of immune system related diseases and disorders; pharmaceutical preparations for the treatment of kidney diseases; pharmaceutical preparations for treating diabetes; pharmaceutical preparations for use in dermatology; pharmaceutical products for ophthalmological use; pharmaceutical products for the prevention and treatment of cancer; pharmaceutical products for the treatment of bone diseases; pharmaceutical products for treating respiratory diseases; pharmaceutical products for treating respiratory diseases and asthma; pharmaceuticals, anti-infectives;i becta;.

Its status is currently believed to be active. Its class is unavailable. “IBECTA” is believed to be currently owned by “NOVARTIS AG”.